Why it took so long to talk about perimenopause
For too long, women’s health was treated as an afterthought. We still haven’t caught up.
For too long, women’s health was treated as an afterthought. We still haven’t caught up.
The FDA-approved pill enlicitide lowers LDL cholesterol by nearly 60 percent, marking the latest advance in medicine’s decades-long fight against…
3 takeaways from Astead Herndon’s conversation with Jim Clyburn.
It may be a big problem for Kalshi and Polymarket.
Lyme disease and alpha-gal syndrome are on the rise, and public health officials aren’t doing enough.
A deal like this has been in the works for years. Experts fear it could spark a new arms race.
Abdul El-Sayed supports Medicare-for-all. Yet his wife’s medical practice doesn’t take Medicare. That illustrates a broader challenge for healthcare reform.
Even moderate Democrats are abandoning their old pro-Israel consensus.
The US inked a deal with the Saudis. A day later, Trump walked it back.
The US cyclospora outbreak is getting worse — and it’s not being helped by poor communications from the Trump administration…